Resident and bone marrow-derived mesenchymal stem cells in head and neck squamous cell carcinoma

47Citations
Citations of this article
55Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Head and neck squamous cell carcinoma (HNSCC) is a major healthcare problem worldwide affecting more than half a million patients each year. Despite considerable advances in the treatment of HNSCC, a high rate of recurrences aggravates the clinical situation and disease outcomes have only modestly improved. Recent insights show that cancer is not only a disease of the transformed epithelium but is also influenced and dependent on its stromal environment. In this review we suggest that resident and bone marrow (BM)-derived mesenchymal stem cells (MSCs) are precursors of the stroma associated with HNSCC and contribute to blood- and lymph angiogenesis, modulate the immune system and produce tumor-associated myofibroblasts. In addition, the impact of radiation therapy on the stromal reaction in HNSCC is discussed. Understanding the mechanisms of how MSCs promote invasive growth and metastasis in HNSCC and respond to cancer management strategies is of profound medical importance and will help us to design improved therapeutic protocols. © 2010 Elsevier Ltd. All rights reserved.

Cite

CITATION STYLE

APA

De Boeck, A., Narine, K., De Neve, W., Mareel, M., Bracke, M., & De Wever, O. (2010, May). Resident and bone marrow-derived mesenchymal stem cells in head and neck squamous cell carcinoma. Oral Oncology. https://doi.org/10.1016/j.oraloncology.2010.01.016

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free